With the ubiquitous use of flow cytometry for CLL diagnosis, subsequent developments have linked several CLL cell-surface proteins, such as a high level of CD38, ZAP-70 and/or CD49d expression, to adverse prognosis (13–15). Here, CD38 is linked to B-cell chronic lymphocytic leukemia.